Similar articles

• Gadobenate dimeglumine-enhanced MRI of the breast: analysis of dose response and comparison with gadopentetate dimeglumine.

  Knopp MV, Bourne MW, Sardanelli F, Wasser MN, Bonomo L, Boetes C, Müller-Schimpfle M, Hall-Craggs MA, Hamm B, Orlacchio A, Bartolozzi C, Kessler M, Fischer U, Schneider G, Oudkerk M, Teh WL, Gehl HB, Salerio I, Pirovano G, La Noce A, Kirchin MA, Spinazzi A. Knopp MV, et al. AJR Am J Roentgenol. 2003 Sep;181(3):663-76. doi: 10.2214/ajr.181.3.1810663. AJR Am J Roentgenol. 2003. PMID: 12933457 Clinical Trial.
• Low-dose gadobenate dimeglumine versus standard-dose gadopentate dimeglumine for delayed contrast-enhanced cardiac magnetic resonance imaging.

  Balci NC, Inan N, Anik Y, Erturk MS, Ural D, Demirci A. Balci NC, et al. Acad Radiol. 2006 Jul;13(7):833-9. doi: 10.1016/j.acra.2006.04.002. Acad Radiol. 2006. PMID: 16777557 Clinical Trial.
• Multicenter, double-blind, randomized, intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for Breast MR imaging (DETECT Trial).

  Martincich L, Faivre-Pierret M, Zechmann CM, Corcione S, van den Bosch HC, Peng WJ, Petrillo A, Siegmann KC, Heverhagen JT, Panizza P, Gehl HB, Diekmann F, Pediconi F, Ma L, Gilbert FJ, Sardanelli F, Belli P, Salvatore M, Kreitner KF, Weiss CM, Zuiani C. Martincich L, et al. Radiology. 2011 Feb;258(2):396-408. doi: 10.1148/radiol.10100968. Epub 2010 Dec 16. Radiology. 2011. PMID: 21163915 Clinical Trial.
• Breast MRI using a high-relaxivity contrast agent: an overview.

  Carbonaro LA, Pediconi F, Verardi N, Trimboli RM, Calabrese M, Sardanelli F. Carbonaro LA, et al. AJR Am J Roentgenol. 2011 Apr;196(4):942-55. doi: 10.2214/AJR.10.4974. AJR Am J Roentgenol. 2011. PMID: 21427349 Review.
• Gadobenate dimeglumine (MultiHance) in MR imaging of the CNS: studies to assess the benefits of a high relaxivity contrast agent.

  Essig M. Essig M. Acad Radiol. 2005 May;12 Suppl 1:S23-7. doi: 10.1016/j.acra.2005.02.020. Acad Radiol. 2005. PMID: 16106542 Review.